Clinical Trial Update: Breath Carbon Monoxide and Cotinine as Biomarkers to Distinguish Smokers From Nonsmokers

View source ↗

Summary

A completed clinical trial evaluating breath carbon monoxide and cotinine as biomarkers to distinguish smokers from nonsmokers in individuals with nicotine depe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Nicotine Dependence | Status: COMPLETED